World's Best Scientists 2026 revealed!
Anton Y. Peleg

Anton Y. Peleg

D-Index & Metrics

Microbiology

D-Index
71
Citations
43882
World Ranking
1800
National Ranking
58

Anton Y. Peleg publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Anton Y. Peleg sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 235 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Anton Y. Peleg D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Anton Y. Peleg sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Anton Y. Peleg is affiliated with Monash University in Australia. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology. Within these main fields, Peleg's work spans several subfields including epidemiology, molecular medicine, infectious diseases, molecular biology, and clinical biochemistry.

The scientist's research covers a range of topics, notably:

  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Antimicrobial Resistance in Staphylococcus
  • Bacterial biofilms and quorum sensing
  • Urinary Tract Infections Management

Peleg has published extensively, with notable recent papers including:

  • "Remdesivir for the Treatment of Covid-19 - Preliminary Report" (2020) in New England Journal of Medicine
  • "Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence" (2020) in Science Immunology
  • "Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials" (2021) in Nature Microbiology
  • "Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study" (2022) in EBioMedicine
  • "Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis" (2022) in Clinical Infectious Diseases

The frequent coauthors contributing to Peleg's work include:

  • Nenad Maćešić
  • Andrew J. Stewardson
  • Luke V. Blakeway
  • Jessica A. Wisniewski
  • Xenia Kostoulias

Research outputs by Peleg have appeared regularly in several publication venues, with the highest number of publications in bioRxiv (Cold Spring Harbor Laboratory). Other frequent venues include:

  • Journal of Antimicrobial Chemotherapy
  • Infection Disease & Health
  • Journal of Global Antimicrobial Resistance
  • Biofilm

Best Publications

  • Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

    Unknown

  • Acinetobacter baumannii: Emergence of a Successful Pathogen

    Anton Yariv Peleg;Harald Seifert;David L Paterson;David L Paterson

  • Hospital-Acquired Infections Due to Gram-Negative Bacteria

    Anton Yariv Peleg;David C Hooper

  • Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial

    Patrick N. A. Harris;Patrick N. A. Harris;Patrick N. A. Harris;Paul A. Tambyah;David C. Lye;David C. Lye;David C. Lye;Yin Mo

  • Common infections in diabetes: pathogenesis, management and relationship to glycaemic control.

    Anton Yariv Peleg;Thilak Weerarathna;James McCarthy;James McCarthy;Timothy M E Davis

  • Medically important bacterial–fungal interactions

    Anton Yariv Peleg;Deborah A Hogan;Eleftherios Mylonakis

  • Treatment of Acinetobacter Infections

    Joel Fishbain;Anton Yariv Peleg;Anton Yariv Peleg

  • Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study

    Anton Yariv Peleg;Shahid Husain;Zubair A Qureshi;Fernanda P Silveira

  • Remdesivir for the Treatment of Covid-19 - Preliminary Report.

    James H. McMahon;Andrew Udy;Anton Y. Peleg

  • Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.

    Anton Yariv Peleg;Sebastian Jara;Divya Monga;George M Eliopoulos;George M Eliopoulos

  • Phenotypic Detection of Carbapenem-Susceptible Metallo-β-Lactamase-Producing Gram-Negative Bacilli in the Clinical Laboratory

    Clare Franklin;Lisa Liolios;Anton Y. Peleg

  • Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

    Yohei Doi;Gerald L. Murray;Anton Y. Peleg;Anton Y. Peleg

  • Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

    Anton Yariv Peleg;Jennifer Adams;David L Paterson

  • Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

    Anton Yariv Peleg;Brian A Potoski;Rhonda Rea;Jennifer Adams

  • The Mechanisms of Disease Caused by Acinetobacter baumannii

    Faye C. Morris;Carina Dexter;Xenia Kostoulias;Muhammad Ikhtear Uddin

  • Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.

    Minggui Wang;Michelle Earley;Liang Chen;Blake M Hanson

  • Management of meningitis due to antibiotic-resistant Acinetobacter species

    Boek Lam Kim;Anton Peleg;Thomas P Lodise;Jeffrey Lipman

  • Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials.

    Fernando Gordillo Altamirano;John H Forsyth;Ruzeen Patwa;Xenia Kostoulias

  • Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.

    Gemma E. Hartley;Emily S.J. Edwards;Pei M. Aui;Nirupama Varese

  • Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody

    Anton Y. Peleg;Shahid Husain;Eun J. Kwak;Fernanda P. Silveira

  • Dissemination of the Metallo-β-Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia

    Anton Y. Peleg;Clare Franklin;Jan M. Bell;Denis W. Spelman

  • Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus

    Anton Y. Peleg;Spiros Miyakis;Spiros Miyakis;Doyle V. Ward;Ashlee M. Earl

  • Candida albicans Hyphal Formation and Virulence Assessed Using a Caenorhabditis elegans Infection Model

    Read Pukkila-Worley;Anton Yariv Peleg;Anton Yariv Peleg;Emmanouil Tampakakis;Eleftherios Mylonakis

Frequent Co-Authors

David L. Paterson
David L. Paterson University of Queensland
Benjamin P. Howden
Benjamin P. Howden University of Melbourne
Allen C. Cheng
Allen C. Cheng Monash University
George M. Eliopoulos
George M. Eliopoulos Beth Israel Deaconess Medical Center
Eleftherios Mylonakis
Eleftherios Mylonakis Houston Methodist
Timothy P. Stinear
Timothy P. Stinear University of Melbourne
Torsten Seemann
Torsten Seemann University of Melbourne
Joseph Meletiadis
Joseph Meletiadis National and Kapodistrian University of Athens
Johan W. Mouton
Johan W. Mouton Radboud University Medical Center
Gustavo C. Cerqueira
Gustavo C. Cerqueira Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various online degree options and career paths that complement this field. For those interested in healthcare, exploring online healthcare degrees that pay well can provide valuable insights into high-demand and well-compensated professions.

Public health is closely linked to microbiology, and many students opt for Master of Public Health (MPH) degrees. If accessibility is a concern, considering the best easiest MPH online programs to get into can help streamline the education process while maintaining quality.

Those with an interest in working with families and children might find a rewarding career as a child life specialist. Understanding the child life specialist salary and associated qualifications can help students make informed decisions about this path.

Importantly, higher education is becoming more inclusive. Students looking for second chances may explore degrees felons can get, ensuring opportunities are available regardless of past challenges.

Best Scientists Citing Anton Y. Peleg

Trending Scientists

Recently Published Articles